Wnt10B is critical for the progression of gastric cancer

Wu,Xiao‑Dan; Bie,Qing‑Li; Zhang,Bin; Yan,Zi‑He; Han,Zhi‑Jun

doi:10.3892/ol.2017.5992

Wnt10B is critical for the progression of gastric cancer

Authors:
- Xiao‑Dan Wu
- Qing‑Li Bie
- Bin Zhang
- Zi‑He Yan
- Zhi‑Jun Han
View Affiliations

Affiliations: Department of Laboratory Medicine, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, Jiangsu 214002, P.R. China, The Key Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Department of Laboratory Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China
Published online on: April 5, 2017 https://doi.org/10.3892/ol.2017.5992
Pages: 4231-4237
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The family of Wnt proteins have been implicated in embryogenesis by regulation of cell fate and pattern formation, and also in human carcinogenesis. Wnt10B was previously shown to be involved in breast cancer development. The present study assessed the association of Wnt10B expression in human gastric cancer tissue specimens with clinicopathological data from these patients. Wnt10B expression in the regulation of gastric cancer cell proliferation and migration capacity in vitro was then investigated. The data revealed that Wnt10B mRNA and protein were upregulated in gastric cancer tissue samples and the upregulated Wnt10B mRNA was associated with gastric cancer metastasizing to lymph nodes. Knockdown of Wnt10B expression reduced gastric cancer cell proliferation and migration, as well as expression of a cell proliferation marker Ki67. Knockdown of Wnt10B expression inhibited tumor cell epithelial‑mesenchymal transition by upregulation of E‑cadherin and downregulation of N‑cadherin. In addition, Wnt10B knockdown also suppressed tumor cell stemness by downregulation of octamer-binding transcription factor 4 and Nanog expression. The present data indicated that Wnt10B expression performs an important role in gastric cancer progression in vitro. Therefore, targeting of Wnt10B expression or activity may be investigated as a possible strategy for the control of gastric cancer.

View Figures

View References

1	Tan YK and Fielding JW: Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 18:821–829. 2006. View Article : Google Scholar : PubMed/NCBI
2	Ding YB, Xia TS, Wu JD, Chen GY, Wang S and Xia JG: Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 203:217–221. 2012. View Article : Google Scholar : PubMed/NCBI
3	Lee YY and Derakhshan MH: Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 16:358–365. 2013.PubMed/NCBI
4	González CA, Sala N and Rokkas T: Gastric cancer: Epidemiologic aspects. Helicobacter. 18 Suppl 1:S34–S38. 2013. View Article : Google Scholar
5	World Cancer Report 2014. World Health Organization. Chapter 5.4. 2014
6	Wang M, Gu H, Qian H, Zhu W, Zhao C, Zhang X, Tao Y, Zhang L and Xu W: miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation. Eur J Cancer. 49:2010–2021. 2013. View Article : Google Scholar : PubMed/NCBI
7	Nusse R and Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 31:99–109. 1982. View Article : Google Scholar : PubMed/NCBI
8	Chen H, Wang Y and Xue F: Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway. Oncol Rep. 29:507–514. 2013.PubMed/NCBI
9	Cadigan KM and Liu YI: Wnt signaling: Complexity at the surface. J Cell Sci. 119:395–402. 2006. View Article : Google Scholar : PubMed/NCBI
10	Kohn AD and Moon RT: Wnt and calcium signaling: Beta-catenin independent pathways. Cell Calcium. 38:439–446. 2005. View Article : Google Scholar : PubMed/NCBI
11	Mao J, Fan S, Ma W, Fan P, Wang B, Zhang J, Wang H, Tang B, Zhang Q, Yu X, et al: Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment. Cell Death Dis. 5:e10392014. View Article : Google Scholar : PubMed/NCBI
12	Katoh M: WNT FGF gene clusters (Review). Int J Oncol. 21:1269–1273. 2002.PubMed/NCBI
13	Mödder UI, Oursler MJ, Khosla S and Monroe DG: Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells. J Cell Biochem. 112:1392–1402. 2011. View Article : Google Scholar : PubMed/NCBI
14	Yoshikawa H, Matsubara K, Zhou X, Okamura S, Kubo T, Murase Y, Shikauchi Y, Esteller M, Herman JG, Wei Wang X and Harris CC: WNT10B functional dualism: Beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. Mol Biol Cell. 18:4292–4303. 2007. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Liu H, Yin J, Wang H, Jiang G, Deng M, Zhang G, Bu X, Cai S, Du J and He Z: FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells. Cell Signal. 27:510–518. 2015. View Article : Google Scholar : PubMed/NCBI
17	Jiang L, Yang YD, Fu L, Xu W, Liu D, Liang Q, Zhang X, Xu L, Guan XY, Wu B, et al: CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. Oncotarget. 5:7663–7676. 2014. View Article : Google Scholar : PubMed/NCBI
18	Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C and Zhang Q: Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 29:1579–1587. 2013.PubMed/NCBI
19	Voon DC, Wang H, Koo JK, Nguyen TA, Hor YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP and Ito Y: Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cell. 30:2088–2099. 2012. View Article : Google Scholar
20	Brown AM: Canonical Wnt signaling: High-throughput RNAi widens the path. Genome Biol. 6:2312005. View Article : Google Scholar : PubMed/NCBI
21	Li C, Song G, Zhang S, Wang E and Cui Z: Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. Oncol Rep. 33:1207–1214. 2015.PubMed/NCBI
22	Qi L, Sun B, Liu Z, Cheng R, Li Y and Zhao X: Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression. J Exp Clin Cancer Res. 33:1072014. View Article : Google Scholar : PubMed/NCBI
23	Shojima K, Sato A, Hanaki H, Tsujimoto I, Nakamura M, Hattori K, Sato Y, Dohi K, Hirata M, Yamamoto H and Kikuchi A: Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively. Sci Rep. 5:80422015. View Article : Google Scholar : PubMed/NCBI
24	Lee FS, Lane TF, Kuo A, Shackleford GM and Leder P: Insertional mutagenesis identities a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci USA. 92:2268–2272. 1995. View Article : Google Scholar : PubMed/NCBI
25	Nusse R and Varmus HE: Wnt genes. Cell. 69:1073–1087. 1992. View Article : Google Scholar : PubMed/NCBI
26	Moon RT, Brown JD and Torres M: WNTs modulate cell fate and behavior during vertebrate development. Trends Genet. 13:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
27	Wend P, Runke S, Wend K, Anchondo B, Yesayan M, Jardon M, Hardie N, Loddenkemper C, Ulasov I, Lesniak MS, et al: WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Mol Med. 5:264–279. 2013. View Article : Google Scholar : PubMed/NCBI
28	Bui TD, Rankin J, Smith K, Huguet EL, Ruben S, Strachan T, Harris AL and Lindsay S: A novel human gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 14:1249–1253. 1997. View Article : Google Scholar : PubMed/NCBI
29	Guan X: Cancer metastases: Challenges and opportunities. Acta Pharm Sin B. 5:402–418. 2015. View Article : Google Scholar : PubMed/NCBI
30	Ye X and Weinberg RA: Epithelial-mesenchymal plasticity: A central regulator of cancer progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
31	Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol. 172:973–981. 2006. View Article : Google Scholar : PubMed/NCBI
32	Takaishi S, Okumura T and Wang TC: Gastric cancer stem cells. J Clin Oncol. 26:2876–2882. 2008. View Article : Google Scholar : PubMed/NCBI
33	Arend RC, Londoño-Joshi AI, Straughn JM Jr and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
34	Holland JD, Klaus A, Garratt AN and Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
35	Bao Z, Wang Y, Yang L, Wang L, Zhu L, Ban N, Fan S, Chen W, Sun J, Shen C and Cui G: Nucleostemin promotes the proliferation of human glioma via Wnt/β-Catenin pathway. Neuropathology. 36:237–249. 2016. View Article : Google Scholar : PubMed/NCBI
36	Wangpu X, Yang X, Zhao J, Lu J, Guan S, Lu J, Kovacevic Z, Liu W, Mi L, Jin R, et al: The metastasis suppressor, NDRG1, inhibits ‘stemness’ of colorectal cancer via down-regulation of nuclear β-catenin and CD44. Oncotarget. 6:33893–33911. 2015.PubMed/NCBI
37	Guo Q and Qin W: DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell. J Cell Mol Med. 19:2832–2841. 2015. View Article : Google Scholar : PubMed/NCBI
38	Burkhalter RJ, Westfall SD, Liu Y and Stack MS: Lysophosphatidic acid initiates epithelial to mesenchymal transition and induces β-catenin-mediated transcription in epithelial ovarian carcinoma. J Biol Chem. 290:22143–22154. 2015. View Article : Google Scholar : PubMed/NCBI